Hormone Blood Test and Treatment: How to Read Your Results

Most people meet their hormones for the first time on a lab report: a neat table of acronyms and numbers with reference ranges that look reassuringly precise. Then the questions start. Why does my TSH look normal when I feel exhausted? Is my estradiol too low for my age? What does free testosterone mean, and why is it different from total? If you are considering hormone treatment or already on hormone replacement therapy, learning to read your results can turn a confusing printout into a useful map.

I have spent years reviewing hormone panels with patients. The patterns repeat, but each person’s context matters. Two individuals with the same number can need very different plans. This guide explains how to think through your hormone blood test in a practical way, and how results tie into treatment options, from traditional HRT to bioidentical hormone therapy, testosterone replacement therapy, thyroid hormone replacement, and more.

First principles: numbers are information, not a verdict

Reference ranges describe the middle 95 percent of values in a population, not your personal optimal zone. A lab can report your cortisol as “normal,” yet you still drag through the morning, sleep poorly, and carry central weight. The key is to match numbers with symptoms, life stage, medical history, medications, and timing of the blood draw. Hormone balancing and hormone optimization are not about chasing a single target. They are about restoring enough signal, at the right time, to relieve symptoms and protect long term health without overshooting.

Three variables quietly drive misinterpretation: timing of sampling, assay method, and binding proteins. If you adjust for those, most results make far more sense.

Timing matters more than most people realize

Hormones pulse and cycle. A single draw gives a snapshot, which might catch the wave or the trough.

    Cortisol follows a circadian rhythm, rising within 30 to 60 minutes after waking, then tapering across the day. A 4 pm sample cannot tell you if your morning peak was adequate. If you want to assess daily pattern, a salivary or dried blood spot panel at four or five timepoints can be useful, but many clinics still start with an 8 am serum cortisol. Thyroid testing is relatively time stable, but illness, pregnancy, and biotin supplements can skew results. Stop high dose biotin at least 48 to 72 hours before testing. Estradiol and progesterone in cycling women hinge on cycle day. For fertility assessment or to evaluate luteal adequacy, draw progesterone about 7 days after ovulation, often cycle day 21 in a 28-day cycle. For perimenopause, estradiol can swing from 40 to 300 pg/mL within a week. One result needs context. Testosterone and LH in men peak in the morning. Draw before 10 am for consistency. If you work nights, align testing to your personal wake time.

If your results do not match your symptoms, repeat the test with better timing before making big decisions.

Assay method and units: small details, big differences

Estradiol can be measured by standard immunoassay or by LC-MS/MS. In men, children, and postmenopausal women where levels are low, immunoassays often overestimate. If you are on testosterone therapy and your estradiol reads unexpectedly high on a common assay, ask for LC-MS/MS before adding an aromatase inhibitor.

Units can confuse. best hormone therapy near me Testosterone may come as ng/dL or nmol/L, estradiol in pg/mL or pmol/L. TSH is in mIU/L. When tracking trends, do not mix units without converting. Labs differ slightly on reference intervals. Stick with the same lab and assay when possible for serial monitoring.

Binding proteins and the free fraction

Hormones travel in blood bound to proteins such as sex hormone binding globulin and albumin. The bound fraction is a reservoir, while the free fraction slips into cells and does the work. Two people can have the same total testosterone, but if one has high SHBG, their free testosterone, and often their symptom relief, will be lower. Thyroid follows a similar principle with thyroid binding globulin, though we assess it indirectly through free T4 and free T3.

SHBG rises with age, estrogen exposure, liver disease, and some medications. It falls with insulin resistance, obesity, hypothyroidism, and androgen use. If you only look at total hormone levels, you miss half the story.

image

Reading the key markers, one by one

Thyroid panel: TSH, free T4, sometimes free T3 and thyroid antibodies

TSH comes from the pituitary. A high TSH with low free T4 means primary hypothyroidism, and thyroid hormone replacement makes sense. A low TSH with high free T4 suggests hyperthyroidism and needs evaluation before any hormone treatment. Some individuals have a TSH in range but still feel hypothyroid, especially if free T3 sits at the bottom of normal or there is Hashimoto’s thyroiditis with positive TPO antibodies. Levothyroxine remains first-line thyroid hormone therapy, yet a subset does better with a small addition of liothyronine or a carefully titrated desiccated thyroid preparation. Technique matters: take thyroid medication on an empty stomach with water, wait 30 to 60 minutes before food or coffee, and separate from iron or calcium by 4 hours.

Reproductive axis in women: estradiol, progesterone, FSH, LH, sometimes prolactin and AMH

Estradiol fuels the follicular phase, rises to trigger an LH surge, and then drops as progesterone takes over in the luteal phase. Low estrogen can drive hot flashes, vaginal dryness, sleep disruption, and bone loss. High estrogen relative to progesterone can worsen heavy menses and breast tenderness in perimenopause. Progesterone’s job is often underappreciated. A mid-luteal progesterone above roughly 10 ng/mL suggests ovulation and reasonable luteal production. In menopause, the ovaries retire, FSH rises, and both estradiol and progesterone fall. HRT for menopause, particularly transdermal estradiol paired with micronized progesterone, helps many women with hot flashes, night sweats, mood swings, brain fog, and sleep issues. For those with a uterus, progesterone or another progestogen is required with systemic estrogen to protect the endometrium.

Reproductive axis in men: total testosterone, free testosterone, SHBG, LH, FSH, estradiol, prolactin

Low testosterone treatment starts with clarity on cause. Primary hypogonadism shows low testosterone with high LH and FSH. Secondary hypogonadism shows low testosterone with low or in-range LH and FSH. Prolactinomas and sleep apnea sit on the list of reversible causes. A morning total testosterone below about 300 ng/dL on two occasions with symptoms supports testosterone replacement therapy. Free testosterone can strengthen the case, particularly if SHBG is high. Estradiol matters more than many men realize. Too low and joints ache, mood sours, libido drops. Too high and gynecomastia or fluid retention can appear. Blanket use of aromatase inhibitors is rarely necessary if dosing and route are chosen thoughtfully.

Adrenal markers: morning cortisol and ACTH

A single 8 am cortisol rules out severe adrenal insufficiency if clearly normal, but it is not a great measure of stress adaptation. For suspected Cushing’s syndrome, use late-night salivary cortisol or low-dose dexamethasone suppression testing. Many clinics offer adrenal hormone therapy, but in evidence-based practice we reserve hydrocortisone for confirmed adrenal insufficiency and use lifestyle, sleep, and targeted medications for stress-related fatigue.

Metabolic hormones: insulin, IGF-1, leptin, and lipids

Insulin resistance distorts many hormone panels. High insulin lowers SHBG, which can inflate free testosterone in women with PCOS. IGF-1 reflects growth hormone status, useful in suspected deficiency or excess. Human growth hormone treatment is a specialized area with strict indications. Off-label HGH therapy for fatigue or fat loss without deficiency carries risks and should not be framed as routine anti-aging hormone therapy.

DHEA and pregnenolone

DHEA-S offers a stable view of adrenal androgen output. DHEA therapy can help in some cases of adrenal androgen deficiency or sexual dysfunction in postmenopausal women, but dose conservatively and check downstream androgens to avoid acne, hair loss, or hirsutism.

A practical reading of common scenarios

A 52-year-old woman with 12 months since her last period has estradiol at 18 pg/mL, FSH at 72 IU/L, and troubling night sweats. Bone density is sliding, and she wakes at 3 am most nights. This pattern matches menopause. Estrogen replacement therapy using a transdermal patch at a physiologic dose often settles sleep, hot flashes, and mood within 2 to 6 weeks. If she has a uterus, add nightly micronized progesterone. The transdermal route has a lower clot risk than oral, and micronized progesterone tends to be friendlier to mood compared with some synthetic progestins. Regular follow up and breast screening continue as usual.

A 39-year-old man reports low libido and difficulty finishing workouts. Morning total testosterone varies between 290 and 360 ng/dL, SHBG is 58 nmol/L, and calculated free testosterone is low. LH sits at 3 IU/L. Sleep study shows untreated sleep apnea. Here, the first move is to treat apnea and review alcohol and medications. If symptoms persist and free testosterone remains low, testosterone therapy has a reasonable chance of benefit. Route matters: injections give peaks and troughs unless dosed more frequently, gels give steady levels but can transfer to partners if not careful, and pellets create long plateaus but make dose adjustment slow. Pick the route that fits daily life, then titrate for symptom relief and lab targets while monitoring hematocrit, estradiol, and PSA by age-appropriate guidelines.

A 34-year-old with irregular cycles, acne, and hair thinning has total testosterone near the top of normal, SHBG low, and free testosterone high. LH to FSH ratio is skewed, and ultrasound shows multiple small follicles. This fits an androgen-dominant pattern like PCOS. The goal is not low hormone treatment but hormone rebalancing through insulin sensitization, weight management, and combined oral contraceptives or other ovulation-regulating strategies. Spironolactone can help acne and hair, but contraception is required due to fetal risks.

A 28-year-old trans woman on gender-affirming hormone therapy takes estradiol and spironolactone. Six months in, estradiol is 180 pg/mL by LC-MS/MS, testosterone is 18 ng/dL, potassium remains normal, and prolactin is slightly elevated but stable. This is typical. Maintain doses, continue regular monitoring, and screen for changes in mood, blood pressure, and lipids. For trans men, testosterone targets and monitoring are similar to cis male TRT, with added attention to bleeding patterns and cervical or breast cancer screening based on anatomy.

Treatment routes, trade-offs, and what to watch

The right hormone treatment depends as much on delivery as on dose. Your body experiences different peaks and valleys with various routes.

Transdermal estrogens deliver steady estradiol, avoid first-pass liver metabolism, and carry a lower clot risk than oral pills. Oral estradiol is convenient but raises hepatic protein synthesis, which can nudge triglycerides and clotting factors. Vaginal estrogen acts locally for dryness without meaningful systemic levels at low doses. Progesterone can be given orally at night, which often improves sleep, or vaginally for more focused endometrial effects.

For testosterone replacement therapy, injections, gels, patches, nasal, and pellet hormone therapy all work when appropriately used. Injections are flexible and affordable. Weekly dosing can produce swings, but splitting to twice weekly or using a smaller daily subcutaneous dose smooths the curve. Gels are simple, but absorption varies and transfer precautions matter. Patches can irritate skin. Hormone pellet implants offer convenience for some patients who prefer not to self-inject or apply daily gels, but the dose cannot be adjusted quickly. If a man develops high hematocrit on injectable TRT, consider lowering dose, increasing frequency, switching to transdermal, checking for sleep apnea, and repleting hydration before resorting to phlebotomy.

Bioidentical hormone therapy uses molecules identical to human hormones, such as estradiol and micronized progesterone. These can be FDA-approved products or compounded formulations. FDA-approved options provide consistent dosing and safety data. Compounded hormone therapy helps in niche cases, like needing a specific estriol to estradiol ratio or an unusual dose not commercially available. Use a reputable compounding pharmacy, and monitor closely. Be cautious with marketing claims. Natural hormone therapy sounds gentle, but potency and risks depend on the molecule, route, and dose, not the label. Synthetic hormone therapy includes many progestins and some estrogens. Some patients do fine on them; others prefer the symptom profile of bioidentical hormones. The choice should be individualized.

Thyroid hormone replacement is straightforward in principle, but in practice it needs patience. Start low, increase every 4 to 6 weeks based on symptoms and labs, and do not chase T3 spikes. For those with persistent symptoms on adequate levothyroxine, a trial of combination therapy with low-dose liothyronine can be reasonable, especially if there is evidence of impaired T4 to T3 conversion. Work with a clinician experienced in integrative hormone therapy or functional medicine hormone therapy if your case is complex, but keep the plan evidence anchored.

Growth hormone and IGF-1 therapy belong in endocrinology. True adult GH deficiency is uncommon and diagnosed with stimulation testing, not a single low IGF-1. Using HGH therapy as an anti-aging hormone treatment without deficiency can cause edema, joint pain, insulin resistance, and carpal tunnel symptoms. Be skeptical of clinics promising rapid fat loss through human growth hormone treatment unless formal criteria are met.

Safety checks that should never be skipped

When patients run into trouble on HRT or TRT, it usually traces back to inadequate screening or lax follow-up. Protect yourself with a few nonnegotiables.

    Before estrogen therapy, assess migraine with aura, clot history, smoking, uncontrolled hypertension, and breast cancer risk. Transdermal routes lower clot risk. In women with prior estrogen receptor positive breast cancer, systemic estrogen is generally avoided, though local vaginal estrogen may still be appropriate under oncology guidance. For testosterone therapy, screen for prostate cancer risk according to age and family history, check baseline hematocrit, lipids, and estradiol, and address sleep apnea. Recheck labs at 6 to 8 weeks, then every 3 to 6 months in the first year, then every 6 to 12 months once stable. Watch hematocrit, PSA by guideline, liver enzymes if on oral androgens, and blood pressure. Thyroid therapy can unmask angina or arrhythmias in older adults. Start low, go slow, and coordinate with cardiology when needed. Cortisol treatment should be reserved for confirmed adrenal insufficiency. Long-term glucocorticoids for nonspecific fatigue do more harm than good. If using compounded bioidentical hormones, document the exact formulation and keep dispensing consistent. Minor compounding differences can change serum levels and symptoms.

Making sense of symptoms when labs look normal

I often meet patients with “normal” labs who feel anything but normal. Sometimes the problem is in the details we already covered, such as high SHBG masking a low free testosterone, or an estradiol immunoassay overreading. Sometimes the issue sits outside the hormone panel. Poor sleep erodes testosterone and growth hormone. Iron deficiency can mimic hypothyroid fatigue. Chronic pain and depression can both flatten libido regardless of hormone levels.

The fastest wins usually come from fixing the basics that intensify hormone swings. Track sleep for two weeks. Reduce alcohol for a month. Add two strength sessions and a few short zone 2 cardio blocks weekly. Increase protein to roughly 1.2 to 1.6 g/kg body weight if safe for your kidneys. These steps shift insulin, SHBG, and leptin in a direction that makes any hormone levels treatment work better.

Two concise tools you can use today

Checklist to prepare for a meaningful hormone panel:

    Time the draw correctly: morning for testosterone and cortisol, mid-luteal for progesterone, and avoid biotin for thyroid. Note all medications and supplements, including DHEA, 5-alpha reductase inhibitors, opioids, and steroids. Align with your symptoms: write down hot flash frequency, sleep hours, libido changes, cycle day, and energy ratings for two weeks. Use the same lab and assay when tracking treatment response. If results and symptoms disagree, repeat the test before changing therapy.

Quick comparison of common hormone delivery routes:

    Transdermal estrogen: steady levels, lower clot risk, skin irritation possible. Oral estrogen: convenient, more hepatic effects, consider in younger low-risk patients. Injectable testosterone: flexible dosing, peaks and troughs unless frequent, monitor hematocrit. Topical testosterone: steady state, variable absorption, transfer precautions. Pellets: convenient long plateaus, slow to adjust, minor procedure required.

How clinicians titrate to effect without chasing extremes

The best hormone specialists do not promise a single magic number. They define a target zone that balances symptom relief, safety markers, and lifestyle fit. For example, in TRT we often aim to bring total testosterone into the mid-normal range for age with a free testosterone that resolves fatigue and libido issues, while keeping estradiol in a physiologic range to protect joints and mood. If hematocrit rises above roughly 52 percent, the first move is to adjust dose and frequency or change route. For menopause treatment, we titrate estradiol to the lowest dose that eliminates vasomotor symptoms, then revisit bone health, vaginal tissue, and sleep. Many women do well on 0.025 to 0.05 mg transdermal patches paired with 100 to 200 mg oral micronized progesterone nightly. In perimenopause, continuous combined regimens can smooth erratic cycles, though some prefer cyclic dosing to mimic natural rhythm.

With thyroid, we adjust levothyroxine to bring TSH into a patient’s sweet spot, often between 0.5 and 2.5 mIU/L for symptom relief, then consider a small T3 addition if fatigue or cold intolerance persists with low-normal free T3. If palpitations or anxiety appear, step back. Subtle overtreatment is common and avoidable.

What about weight gain, brain fog, and low libido?

Weight gain clusters with insulin resistance, sleep loss, perimenopausal estrogen swings, and low testosterone in men. HRT can reduce central fat gain in early menopause, but it does not replace food quality, strength training, and sleep. For persistent weight challenges, look at medications like GLP-1 receptor agonists alongside hormone balancing if appropriate, and track waist circumference, not just the scale.

Brain fog often reflects sleep disruption, iron or B12 deficits, mood disorders, and perimenopausal fluctuations. Estrogen and progesterone therapy help many women think more clearly within weeks. In men, TRT can improve attention when low T is part of the picture, but untreated apnea will blunt the benefit.

Low libido is multifactorial. In women, estrogen improves comfort, testosterone at low female doses can increase desire, and addressing pain, relationship stress, and medications like SSRIs matters. In men, libido tracks more closely with free testosterone than total, but intimacy, stress, and porn overuse can also shape desire. Honest conversation usually helps more than another milligram.

When to see a specialist and how to choose one

Simple cases can be managed by a primary care clinician. Seek a hormone doctor or endocrinologist for complex thyroid disease, suspected adrenal disorders, pituitary issues, or when standard HRT attempts fail. A good hormone clinic will ask detailed questions, discuss risks and benefits, monitor at sensible intervals, and resist one-size-fits-all protocols. Be cautious of anyone who promises regenerative hormone therapy that cures everything or who pushes high-dose compounded bioidentical hormones without measuring levels and safety markers.

Ask how the clinic handles:

    Baseline screening, including cancer and clot risks. Monitoring frequency and which markers they track. Dose adjustments for side effects like high hematocrit or breast tenderness. Coordination with your other physicians.

Pulling it together

Reading your hormone blood test is about pattern recognition informed by timing, assay choice, binding proteins, and lived symptoms. Treatment is about careful calibration, not maximal dosing. Bioidentical hormone replacement therapy can be a good fit for many, and synthetic options remain perfectly appropriate for others. Testosterone optimization helps when true deficiency exists and underlying issues are addressed. Thyroid hormone replacement restores energy when TSH and free hormones show a mismatch between supply and demand.

With sound testing, thoughtful interpretation, and respectful follow-up, hormone imbalance treatment becomes predictable work. You do not need perfect numbers, just the right signals at the right time for your physiology. When the labs and your life start telling the same story, you will feel it: steadier energy, better sleep, clearer thinking, and a body that finally hums along at the pace it was meant to keep.